Cibc Private Wealth Group, LLC Celldex Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 500 shares of CLDX stock, worth $18,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$18,380% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
208Shares Held
61.1MCall Options Held
291KPut Options Held
246K-
Wellington Management Group LLP Boston, MA7.65MShares$281 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.51MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.65MShares$134 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.12MShares$115 Million2.11% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$113 Million0.02% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.72B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...